BRIEF published on 07/16/2026 at 09:12, 2 months 30 days ago Valerio Therapeutics and Abivax join forces for innovative therapies Abivax Collaboration Inflammatory Diseases Valerio Therapeutics RNA Therapies
PRESS RELEASE published on 07/16/2026 at 09:07, 2 months 30 days ago Inside Information / Other news releases Valerio Therapeutics partners with Abivax for global collaboration, providing pipeline update on RNA therapeutics. Initial payment up to €2.4 million Abivax Collaboration Valerio Therapeutics Pipeline Update RNA Therapeutics
PRESS RELEASE published on 07/16/2026 at 09:07, 2 months 30 days ago Informations privilégiées / Autres communiqués Valerio Therapeutics annonce une collaboration de développement avec Abivax, met à jour son pipeline de thérapies de précision ARN Développement Abivax Collaboration Pipeline Valerio Therapeutics
BRIEF published on 07/01/2026 at 09:27, 3 months 14 days ago Valerio Therapeutics Proposes to Acquire Etherna Immunotherapies Biotechnology Valerio Therapeutics Acquisition Deal RNA Medicines Etherna Immunotherapies
BRIEF published on 07/01/2026 at 09:27, 3 months 14 days ago Valerio Therapeutics is preparing to acquire Etherna Immunotherapies Valerio Therapeutics Biotechnology Investment Etherna Acquisition RNA Drugs Mergers Of Companies
BRIEF published on 07/01/2026 at 09:27, 3 months 14 days ago Valerio Therapeutics propose d'acquérir Etherna Immunotherapies Biotechnologie Accord D'acquisition Valerio Thérapeutique Médicaments À Base D'ARN Immunothérapies Etherna
BRIEF published on 07/01/2026 at 09:27, 3 months 14 days ago Valerio Therapeutics prépare l'acquisition d'Etherna Immunotherapies Valerio Therapeutics Investissement Biotechnologie Acquisition Etherna Médicaments ARN Fusion Entreprises
PRESS RELEASE published on 07/01/2026 at 09:22, 3 months 14 days ago Inside Information / Other news releases Valerio Therapeutics announces binding offer to acquire Etherna Immunotherapies, creating global leader in targeted RNA medicines. Strategic move unlocked by leading investors Acquisition Valerio Therapeutics RNA Medicines Targeted Delivery Etherna Immunotherapies
PRESS RELEASE published on 07/01/2026 at 09:22, 3 months 14 days ago Informations privilégiées / Autres communiqués Valerio Therapeutics annonce l'acquisition d'Etherna Immunotherapies, devenant ainsi un leader mondial des médicaments à base d'ARN ciblés. L'opération vise à combiner deux technologies pour le développement de nouveaux traitements Acquisition Innovation Biotechnologie Valerio Therapeutics Médicaments ARN Ciblés
BRIEF published on 06/16/2026 at 19:48, 3 months 28 days ago Valerio Therapeutics nomme un nouveau PDG et confirme les résolutions de son assemblée générale annuelle Biotechnologie Transition Du PDG Valerio Thérapeutique Gilles Besin Médicaments À Base D'ARN
Published on 10/15/2026 at 16:10, 1 hour 50 minutes ago North Shore Announces Extension to Falcon Property Option Agreement and Resource Stock Digest Engagement
Published on 10/15/2026 at 15:15, 2 hours 45 minutes ago Gold Terra to Host Community Town Hall Meeting in Yellowknife on October 21, 2026
Published on 10/15/2026 at 14:31, 3 hours 29 minutes ago First Breach to Present at the 20th Annual LD Micro Main Event
Published on 10/15/2026 at 14:05, 3 hours 55 minutes ago Innodata to Report Third Quarter 2026 Results
Published on 10/15/2026 at 14:00, 4 hours ago Tectonic Metals Drills 2.41 g/t Au over 59.44 metres, Including 11.82 g/t Au over 10.67 metres and 39.96 g/t Au over 3.05 metres at Alpha Bowl, Flat Gold Project, Alaska
Published on 10/15/2026 at 16:55, 1 hour 5 minutes ago Verlingue consolidates its international offering by integrating Verlingue Portugal into the WBN network
Published on 10/15/2026 at 16:50, 1 hour 10 minutes ago Good Brands AG: Portfolio under management grows to EUR 139 million in LTM revenue – sharpened focus on high-growth investments
Published on 10/15/2026 at 16:33, 1 hour 27 minutes ago EQS-Adhoc: Good Brands AG: Portfolio Clean-up – Impairment of Investments
Published on 10/15/2026 at 16:05, 1 hour 55 minutes ago webhotelier | primalres rebrands as revplus, entering the era of a unified ecosystem
Published on 10/15/2026 at 17:45, 15 minutes ago Entech remporte un contrat EPC portant sur une centrale de stockage d’énergie par batterie (BESS) de 180 MWh
